This week, the Center on Health Equity & Access featured expert perspectives on sickle cell disease, obesity, psychological safety, LGBTQ+ health, and postpartum depression.
Elevating Equitable Health Care for the LGBTQ+ Community
This episode of Managed Care Cast, part of the Pride Month 2024 series, features Patrick McGovern, the CEO of Callen-Lorde since August 2023. As a seasoned advocate for HIV and LGBTQ+ community health, he discussed his extensive career dedicated to equitable health care. McGovern, who is openly gay, also reflected on his personal and professional commitment to addressing the health disparities faced by LGBTQ+ individuals and people living with HIV.
In honor of World Sickle Cell Day, this feature article reviewed the milestone moments for the community from the last year. At the end of 2023, the FDA approved 2 innovative gene therapies, exa-cel and lovo-cel, offering potential cures for sickle cell disease (SCD). However, they present significant challenges, including high costs, complex logistics, and limited accessibility. To address these barriers, initiatives like the upcoming Cell and Gene Therapy Access Model aim to improve access for Medicaid-insured individuals. Meanwhile, ongoing advocacy and research continue to seek broader, more equitable treatment options for all within the SCD community.
Dr Rachel Dalthorp: Zuranolone Improves Access to Postpartum Depression Treatment
Zuranolone (Zurzuvae) has revolutionized postpartum depression (PPD) treatment by offering the first oral medication that can be taken at home. Unlike the older intravenous infusion brexanolone, which requires hospital monitoring, zuranolone provides rapid relief without separating mothers from their babies. Rachel Dalthorp, MD, explained that this neurosteroid significantly improves care for mothers, allowing them to manage PPD effectively and conveniently at home.
Contributor: Improving Health Care Through Psychological Safety
In an article authored by Carolyn Tandy, senior vice president and chief diversity, equity, and inclusion officer of Humana, she addressed the increasing burnout and resignations among US workers and how it's impacted patient care and public health. Psychological safety, where employees feel safe to speak up and be themselves without fear, is essential. Most employees prioritize workplaces that value their well-being, according to a recent survey highlighted. Tandy emphasized that leaders must promote a safe, inclusive workplace to empower staff and enhance patient care.
Obesity Management in 2024: A Look at the CINEMA Program’s Growth and Impact
At a recent Institute for Value-Based Medicine® event hosted by The American Journal of Managed Care® and University Hospitals in Cleveland, Ian Neeland, MD, discussed the success and growth of the CINEMA program at University Hospitals in Cleveland, which he directs. He highlighted the challenges in obesity management for 2024, exacerbated by a shortage of semaglutide, a key treatment for diabetes and obesity. Neeland also emphasized the need for more resources and education to address the high demand for obesity care.
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Low Pulmonary Rehabilitation, Palliative Care Referrals for Patients With IPF Persist
October 30th 2024Despite proven benefits, referrals to pulmonary rehabilitation and palliative care for patients with idiopathic pulmonary fibrosis (IPF) in England remain significantly lower than for other respiratory conditions.
Read More
New AI Tool Identifies Undiagnosed PNH in Health Records
October 30th 2024The machine learning model shows promise in detecting paroxysmal nocturnal hemoglobinuria (PNH) by assessing electronic health records (EHR) data, potentially transforming the diagnostic landscape for rare diseases.
Read More